According to Custom Market Insights (CMI), the global CBD product market was valued at approximately USD 3 billion in 2021 and is projected to grow significantly, reaching an estimated USD 33 billion by 2030. This reflects a compound annual growth rate (CAGR) of about 11% from 2022 to 2030. The comprehensive research report presents a holistic analysis of the market, focusing on the key drivers and restraints that influence demand over the forecast period. Additionally, the report explores global opportunities and offers a detailed competitive landscape for the CBD product market.

CBD Product Market: Overview

CBD-infused products are increasingly being used to address a variety of health and wellness concerns, such as anxiety, stress, insomnia, migraines, skincare issues, seizures, joint pain and inflammation, neurological disorders, and other conditions. Among these, managing chronic pain has emerged as one of the most popular applications, largely due to CBD’s wide-ranging therapeutic benefits. The increasing demand for CBD products is attributed to their effectiveness in alleviating chronic pain through interactions with several biological systems in the human body.

CBD has been observed to possess analgesic, anti-inflammatory, and antioxidant properties, which help reduce pain and associated anxiety in chronic conditions. As awareness of these benefits continues to grow, the popularity and usage of CBD products are expected to expand further.

To access the full report titled “CBD Product Market Size, Trends and Insights By Source (Hemp, Marijuana), By Distribution Channel (B2B, B2C), By Application (Pharmaceutical, Wellness), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2022–2030,” visit https://www.custommarketinsights.com/report/cbd-product-market/

Growth Factors

Over the last two decades, the legalization and regulation of cannabis for both medicinal and recreational purposes have gained momentum globally. This regulatory progress has led to a rapid surge in the demand for cannabis-based products, including those containing cannabidiol (CBD). However, it is crucial to implement and follow clear regulatory frameworks to ensure consumer safety and product standardization.

Cannabis remains one of the most widely cultivated, transported, and misused illicit substances across the globe. Nevertheless, legal reform efforts, ballot measures, and shifts in public sentiment—especially in the United States—demonstrate increasing acceptance of cannabis use. According to a recent Quinnipiac University survey, 54% of American voters support the legalization of cannabis without added restrictions, while 81% advocate for its decriminalization for medical purposes. As legalization continues to expand worldwide, it is expected to fuel consistent growth in demand, thereby contributing to the overall expansion of the CBD product market.

Segmental Overview

The CBD product market is segmented based on source, distribution channel, and application. In terms of application, the market is categorized into pharmaceutical and wellness segments. The wellness category further encompasses personal care and cosmetics, food and beverages, nutraceuticals, and other subsegments.

CBD oil is now a common ingredient in skincare products targeting acne and wrinkles. Major beauty retailers are incorporating CBD into their offerings—Sephora, for example, has launched a dedicated range of CBD skincare products, while Ulta Beauty is also planning to introduce a specialized line of CBD-infused items. These efforts highlight the growing interest in CBD-enriched beauty products, which is driving significant innovation and competition in the wellness segment.

Governments and key industry players are allocating more resources to research and development in the CBD space. Clinical trials have shown promising results for the use of cannabidiol in treating conditions like epilepsy. For instance, GW Pharmaceuticals’ drug Epidiolex has demonstrated efficacy in Phase III trials conducted in the UK, specifically for managing Dravet syndrome and Lennox-Gastaut syndrome—two forms of treatment-resistant epilepsy. These developments are likely to enhance the credibility and adoption of CBD products in therapeutic and wellness applications.

To request a free sample copy of the report, visit: https://www.custommarketinsights.com/request-for-free-sample/?reportid=23070

Regional Overview

In 2021, North America accounted for more than 85% of the global CBD product market revenue, and it is expected to maintain its dominant position in the years ahead. Several factors contribute to this strong market presence, including a large population with health and wellness awareness, increasing consumer acceptance of CBD-based products, the presence of established manufacturers, and the implementation of the U.S. Farm Bill in 2020. North America remains the most progressive region in terms of cannabis and CBD usage and regulation. The majority of global CBD companies operate out of this region, benefiting from relatively relaxed legal conditions.

Outside North America, substantial market growth is projected in regions such as Europe and Asia Pacific, supported by the development of hemp cultivation facilities. China, in particular, is a leading force in hemp production, accounting for nearly half of global output. Three Chinese provinces have started cultivating hemp specifically for CBD extraction.

Countries like the United States, Germany, the United Kingdom, the Netherlands, and Japan currently dominate CBD product exports, accounting for roughly 90% of global trade. However, with the introduction of favorable government policies, lower production costs, and extensive manufacturing infrastructure, hemp producers in China and other emerging economies are poised to offer strong competition to North American and European suppliers.

Prominent Market Players

Key players in the global CBD product market include:

INSYS Therapeutics, Inc.
EPIDIOLEX
SolMic GmbH
ENDOCA
Folium Biosciences
Cannoid, LLC
Marijuana Company of America Inc.
Pivot Pharmaceuticals Inc.
HoneyB Healthy
NuLeaf Naturals, LLC
Nightfood Holdings
Medical Marijuana, Inc.
Pharmahemp d.o.o.
Isodiol International, Inc.
Others

For a detailed look at the report’s table of contents, visit: https://www.custommarketinsights.com/report/cbd-product-market/#table-of-contents

https://www.custommarketinsights.com/report/cbd-product-market/